Latest stories on OSTX
OS Therapies Ends At-The-Market Equity Sales Program
TipRanks53 · neutralgeneral
OS Therapies Inc (OSTX) files 8-K
SEC 8-K50 · neutralgeneral
OS Therapies Accepts New FDA Meeting Request to Review Biomarker Data as Part of BEST Program | OSTX Stock News
StockTitan67 · bullishproduct/pr
8-K/A - OS Therapies Inc (OSTX) files 8-K
SEC 8-K50 · neutralgeneral
OS Therapies Third Quarter 2026 Corporate Outlook | OSTX Stock News
StockTitan56 · neutralgeneral
OS Therapies Secures Convertible Note Financing for Expansion
TipRanks28 · bearishgeneral
OS Therapies Inc (OSTX) files 8-K
SEC 8-K50 · neutralgeneral
OS Therapies Appoints Dr. Craig Eagle to Board of Directors | OSTX Stock News
StockTitan56 · neutralgeneral
OS Therapies Provides U.S. Regulatory Update | OSTX Stock News
StockTitan63 · neutralproduct/pr
OS Therapies Announces the Publication of Four Articles on OST-HER2 and Osteosarcoma in Drug Discovery World | OSTX Stock News
StockTitan63 · neutralproduct/pr
OS Therapies to Attend Upcoming Medical, Financial and Industry Conferences | OSTX Stock News
StockTitan56 · neutralproduct/pr